MedTrace Logo

Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System

NCT02418871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2021-05-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical outcomes of an investigational IOL in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.

Conditions

  • Aphakia

Interventions

DEVICE

FluidVision AIOL

Investigational implantable medical device intended for long-term use over the lifetime of the cataract subject. An improved injector system was used.

PROCEDURE

Cataract surgery

Performed using standard microsurgical techniques

Sponsors & Collaborators

  • PowerVision

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-13
Primary Completion
2016-03-16
Completion
2018-09-05
FDA Device
Yes

Countries

  • Hungary
  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02418871 on ClinicalTrials.gov